CTC
DGX icon

Central Trust Company’s Quest Diagnostics DGX Stock Holding History

Central Trust Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$295K Hold
1,505
– – 0.01% 518
2025
Q4 		$261K Sell
1,505
-700
-32% -$127K 0.01% 533
2025
Q3 		$420K Sell
2,205
-95
-4% -$16.9K 0.01% 452
2025
Q2 		$413K Sell
2,300
-119
-5% -$20.7K 0.01% 442
2025
Q1 		$409K Sell
2,419
-265
-10% -$43.5K 0.01% 438
2024
Q4 		$405K Buy
2,684
+417
+18% +$64.9K 0.01% 440
2024
Q3 		$352K Sell
2,267
-23
-1% -$3.44K 0.01% 462
2024
Q2 		$314K Sell
2,290
-133
-5% -$18.2K 0.01% 481
2024
Q1 		$323K Sell
2,423
-40
-2% -$5.19K 0.01% 493
2023
Q4 		$340K Sell
2,463
-63
-2% -$8.28K 0.01% 461
2023
Q3 		$308K Sell
2,526
-339
-12% -$45.2K 0.01% 478
2023
Q2 		$403K Sell
2,865
-700
-20% -$96.5K 0.01% 450
2023
Q1 		$504K Buy
3,565
+236
+7% +$33.8K 0.01% 407
2022
Q4 		$521K Sell
3,329
-60
-2% -$8.62K 0.02% 385
2022
Q3 		$415K Buy
3,389
+955
+39% +$126K 0.01% 403
2022
Q2 		$324K Sell
2,434
-23
-0.9% -$3.13K 0.01% 443
2022
Q1 		$336K Sell
2,457
-40
-2% -$5.58K 0.01% 475
2021
Q4 		$432K Sell
2,497
-110
-4% -$16.7K 0.01% 461
2021
Q3 		$379K Buy
2,607
+358
+16% +$52.4K 0.01% 455
2021
Q2 		$296K Buy
2,249
+15
+0.7% +$1.96K 0.01% 474
2021
Q1 		$287K Buy
2,234
+125
+6% +$15.4K 0.01% 459
2020
Q4 		$251K Sell
2,109
-24
-1% -$2.93K 0.01% 452
2020
Q3 		$244K Sell
2,133
-471
-18% -$55.6K 0.01% 424
2020
Q2 		$297K Buy
2,604
+135
+5% +$14.3K 0.01% 390
2020
Q1 		$198K Sell
2,469
-50
-2% -$5.18K 0.01% 416
2019
Q4 		$269K Sell
2,519
-300
-11% -$31.3K 0.01% 417
2019
Q3 		$302K Sell
2,819
-15
-0.5% -$1.54K 0.02% 387
2019
Q2 		$293K Buy
2,834
+285
+11% +$27.4K 0.02% 400
2019
Q1 		$229K Buy
2,549
+50
+2% +$4.33K 0.01% 418
2018
Q4 		$208K Buy
2,499
+300
+14% +$28.1K 0.01% 425
2018
Q3 		$238K Hold
2,199
– – 0.01% 447
2018
Q2 		$241K Hold
2,199
– – 0.02% 431
2018
Q1 		$220K Buy
2,199
+250
+13% +$25.6K 0.01% 447
2017
Q4 		$192K Sell
1,949
-50
-3% -$4.74K 0.01% 483
2017
Q3 		$187K Sell
1,999
-100
-5% -$10.6K 0.01% 466
2017
Q2 		$233K Buy
2,099
+55
+3% +$5.82K 0.02% 427
2017
Q1 		$200K Sell
2,044
-196
-9% -$18.7K 0.01% 452
2016
Q4 		$206K Sell
2,240
-15
-0.7% -$1.29K 0.01% 447
2016
Q3 		$191K Sell
2,255
-75
-3% -$6.3K 0.01% 443
2016
Q2 		$189K Sell
2,330
-25
-1% -$1.9K 0.01% 449
2016
Q1 		$168K Sell
2,355
-350
-13% -$23.5K 0.01% 458
2015
Q4 		$192K Sell
2,705
-165
-6% -$11.1K 0.02% 432
2015
Q3 		$176K Hold
2,870
– – 0.02% 435
2015
Q2 		$209K Sell
2,870
-10
-0.3% -$738 0.02% 423
2015
Q1 		$221K Sell
2,880
-25
-0.9% -$1.79K 0.02% 411
2014
Q4 		$195K Buy
2,905
+250
+9% +$15.8K 0.02% 423
2014
Q3 		$161K Hold
2,655
– – 0.01% 458
2014
Q2 		$156K Hold
2,655
– – 0.01% 463
2014
Q1 		$154K Sell
2,655
-5,039
-65% -$270K 0.01% 463
2013
Q4 		$412K Sell
7,694
-970
-11% -$57.5K 0.03% 317
2013
Q3 		$536K Buy
8,664
+550
+7% +$32.9K 0.05% 277
2013
Q2 		$492K Buy
+8,114
New +$483K 0.05% 274

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Central Trust Company's DGX Position: Q1 2026 in Review

Central Trust Company held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,505 shares worth $295K. The position accounts for 0.01% of the portfolio, ranked #518.

Central Trust Company first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $536K in Q3 2013. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Central Trust Company held 1,505 shares of Quest Diagnostics worth $295K as of Q1 2026.
  • Central Trust Company left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.01% of Central Trust Company's portfolio in Q1 2026, its #518 holding.
  • Central Trust Company first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's Quest Diagnostics position peaked at $536K in Q3 2013.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.